at-13387 and Leukemia--Myeloid--Acute

at-13387 has been researched along with Leukemia--Myeloid--Acute* in 1 studies

Other Studies

1 other study(ies) available for at-13387 and Leukemia--Myeloid--Acute

Article	Year
HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics. Leukemia & lymphoma, 2019, Volume: 60, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Benzamides; Cell Line, Tumor; Cytosine; DNA Breaks, Double-Stranded; DNA Repair; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Leukemia, Myeloid, Acute	2019

Article

Year

HSP90 inhibition depletes DNA repair proteins to sensitize acute myelogenous leukemia to nucleoside analog chemotherapeutics.

Leukemia & lymphoma, 2019, Volume: 60, Issue:9

Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Benzamides; Cell Line, Tumor; Cytosine; DNA Breaks, Double-Stranded; DNA Repair; Drug Resistance, Neoplasm; HSP90 Heat-Shock Proteins; Humans; Isoindoles; Leukemia, Myeloid, Acute

2019